Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

122 public trials 26 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Recruiting

Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy

NCT06357754

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia, +20 more
Locations
  • Local Institution - 0016 Portland, Oregon, United States
  • Ut Southwestern Dallas, Texas, United States
  • Huntsman Cancer Institute at the University of Utah Salt Lake City, Utah, United States
  • Local Institution - 0004 Madison, Wisconsin, United States
View Trial Details
Recruiting

Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID Project

NCT06821880

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Lymphocytic Leukaemia (CLL), +20 more
Locations
  • Medizinische Universität Innsbruck Innsbruck, Tyrolia, Austria
  • Medizinische Universität Graz Graz, Austria
  • BKH Kufstein Kufstein, Austria
  • Onkologischer Schwerpunkt am Oskar-Helene-Heim Berlin, Germany
View Trial Details
Recruiting

CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+

NCT06355739

Conditions
B Lymphoblastic Lymphoma, B Lymphocytic Leukemia, Hematologic Diseases, +12 more
Locations
  • Department of Pediatrics, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
  • InstituteHBDH Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

NCT03852407

Conditions
Acute Lymphoid Leukemia in Remission, Acute Myeloid Leukemia in Remission, Blood Protein Disorders, +33 more
Locations
  • ZNA Stuivenberg Antwerp, Belgium
  • AZ Sint Jan Brugge Bruges, Belgium
  • IJ Bordet Brussels, Belgium
  • UZ Brussel Brussels, Belgium
View Trial Details

Related conditions